Oxford Wealth Group LLC Has $371,000 Holdings in Lam Research Co. (NASDAQ:LRCX)

Oxford Wealth Group LLC lifted its stake in Lam Research Co. (NASDAQ:LRCX - Free Report) by 1,348.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,142 shares of the semiconductor company's stock after acquiring an additional 4,787 shares during the period. Oxford Wealth Group LLC's holdings in Lam Research were worth $371,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. West Oak Capital LLC grew its stake in Lam Research by 50.9% during the fourth quarter. West Oak Capital LLC now owns 400 shares of the semiconductor company's stock worth $29,000 after buying an additional 135 shares in the last quarter. Diversified Trust Co boosted its position in shares of Lam Research by 8.3% during the 4th quarter. Diversified Trust Co now owns 3,741 shares of the semiconductor company's stock worth $270,000 after acquiring an additional 286 shares in the last quarter. McLean Asset Management Corp boosted its position in shares of Lam Research by 6.3% during the 4th quarter. McLean Asset Management Corp now owns 5,122 shares of the semiconductor company's stock worth $370,000 after acquiring an additional 302 shares in the last quarter. Fairway Wealth LLC increased its stake in Lam Research by 900.0% in the fourth quarter. Fairway Wealth LLC now owns 340 shares of the semiconductor company's stock valued at $25,000 after acquiring an additional 306 shares during the last quarter. Finally, Householder Group Estate & Retirement Specialist LLC raised its position in Lam Research by 159.1% during the fourth quarter. Householder Group Estate & Retirement Specialist LLC now owns 500 shares of the semiconductor company's stock valued at $36,000 after purchasing an additional 307 shares in the last quarter. Institutional investors own 84.61% of the company's stock.

Lam Research Trading Up 1.7 %

LRCX opened at $63.48 on Wednesday. The stock has a market cap of $81.49 billion, a PE ratio of 19.28, a price-to-earnings-growth ratio of 1.47 and a beta of 1.52. The company has a quick ratio of 1.73, a current ratio of 2.54 and a debt-to-equity ratio of 0.51. Lam Research Co. has a twelve month low of $56.32 and a twelve month high of $113.00. The company has a fifty day moving average of $74.01 and a 200-day moving average of $75.68.

Lam Research (NASDAQ:LRCX - Get Free Report) last posted its quarterly earnings data on Wednesday, January 29th. The semiconductor company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.87 by $0.04. Lam Research had a return on equity of 51.86% and a net margin of 26.49%. On average, sell-side analysts predict that Lam Research Co. will post 3.71 EPS for the current year.

Lam Research Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, April 9th. Stockholders of record on Wednesday, March 5th were given a dividend of $0.23 per share. This represents a $0.92 annualized dividend and a dividend yield of 1.45%. The ex-dividend date of this dividend was Wednesday, March 5th. Lam Research's dividend payout ratio (DPR) is 27.96%.

Insider Activity

In other news, SVP Seshasayee Varadarajan sold 110,080 shares of the firm's stock in a transaction dated Thursday, February 20th. The stock was sold at an average price of $90.00, for a total value of $9,907,200.00. Following the completion of the sale, the senior vice president now directly owns 179,084 shares in the company, valued at $16,117,560. This trade represents a 38.07 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. 0.29% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

LRCX has been the topic of a number of research analyst reports. Oppenheimer decreased their price target on Lam Research from $95.00 to $80.00 and set an "outperform" rating on the stock in a research note on Friday, April 11th. Wells Fargo & Company lifted their target price on Lam Research from $82.00 to $85.00 and gave the company an "equal weight" rating in a research report on Thursday, January 30th. Jefferies Financial Group increased their target price on shares of Lam Research from $95.00 to $100.00 and gave the stock a "buy" rating in a report on Friday, March 28th. Sanford C. Bernstein raised shares of Lam Research from a "market perform" rating to an "outperform" rating and lifted their price target for the company from $85.00 to $91.00 in a report on Thursday, January 30th. Finally, UBS Group lowered their price objective on shares of Lam Research from $95.00 to $90.00 and set a "buy" rating for the company in a research report on Monday, April 14th. Six investment analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $93.63.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Co. (NASDAQ:LRCX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.